Amrita Nallathambi, PhD

Protein Designer

Ana-Maria Bratovianu, MSc

Scientist & Co-Founder

Areso Ahmadsay, MSc

Admin & Operations

Bryan Roth, MD, PhD

Advisor

Bryan White

Board Member & Co-Founder

Chris Norn, PhD

CEO / Co-Founder / Board Member

Chris Norn co-founded Skape Bio with Nobel Prize winner David Baker to advance GPCR therapeutics with AI-designed biologics. He helped raise $9M to build and validate the company’s platform. Previously in the Baker Lab, Chris helped pioneer AI-driven protein design, contributing to breakthroughs including AI-designed enzymes, self-assembling nanoparticles, and the first de novo designed GPCR-activating biologic. His work focuses on translating computational design into practical medicines by creating precise, programmable proteins that modulate GPCR signaling, and Skape Bio is actively exploring platform partnerships with biopharma.

Chris Tate, PhD

Advisor

David Baker, PhD

Board Observer & Co-Founder

David Feldman, PhD

Advisor

David Kim, PhD

Advisor

David Younger, PhD

Advisor

Dima Borisevich, PhD

Director of Data Engineering

Edin Muratspahic, PhD

Advisor

Emil Hertz, PhD

Head of Discovery

Henrik Stage

Board Member & Co-Founder

Jakob Staun Pallesen

Board Observer

Jan Voss, PhD

Lead Pharmacologist

Lance Stewart, PhD, MBA

Board Chair & Co-Founder

Lene Jessen, PhD

VP of Translational Biology & Pharmacology

Mads Jeppesen, PhD

Protein Designer

Malcolm Weir, PhD

Advisor

Marina Mohr, PhD

Director of Operations & Strategy

Mark Gurney, PhD, MBA

Advisor

Matt Barnes, PhD

Chief Scientific Officer

Matt Barnes, PhD, is the CSO of Skape Bio, bringing over 25 years of R&D leadership in the pharmaceutical and biotech sectors. An expert in GPCRs, ion channels, and transporters, Matt most recently served as EVP and Chief Scientific Officer at Nxera Pharma UK (formerly Sosei Heptares). There, he led the expansion of UK R&D operations, successfully transitioning over 10 preclinical candidates and three clinical assets in a five-year span. Matt is a Fellow of the British Pharmacological Society and an active scientific advisor within the biotech ecosystem, recognized for driving high-value global partnerships with leading pharma and biotech companies.

Mette Rosenkilde, PhD

Advisor

Paula Rivera Sánchez, MSc

Scientist & Co-Founder

Pia Peceli, MSc

Research Assistant

Robert Blazej

Board Observer

Samuel Pine, PhD

VP of DMPK